White Paper

Parkview Health

To improve patient outcomes and increase health equity, Parkview Health has brought Digital Diagnostics’ FDA cleared artificial intelligence system, LumineticsCore™ (formerly IDx-DR), to the point-of-care to improve comprehensive diabetes management through the autonomous detection of diabetic retinopathy (including macular edema).

Read this white paper to find out more about Parkview Health and LumineticsCore

  • 3 lab and endo facilities providing LumineticsCore exams at the point-of-care
  • 326 patients tested for diabetic retinopathy eye disease using LumineticsCore in 2021
  • 46% of patients tested positive for diabetic eye disease

Download White Paper

Fill out this form to download the Parkview Health white paper

White Paper

Parkview Health - White Paper